π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This phase I/II trial studies the side effects and best way to give laborat...
Status
Terminated
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2013-02
Trial ID
NCT01758458
The intra-/perilesional application of interleukin-2 seems to be a safe and...
Status
Completed
Location
Skin Cancer Program, Department of Dermatology, Liebermeisterstrasse 8
Start Date
2003-08
Trial ID
NCT00204581
Treatments Being Tested
The investigators aim to include 100 local participants over the next 5 yea...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-12-01
Trial ID
NCT03928275
Treatments Being Tested
This clinical study investigates the immunological effects of tuberculin pu...
Status
Completed
Location
Venereology Clinic, Dr. Hasan Sadikin Hospital
Start Date
2022-04-01
Trial ID
NCT07072065
Treatments Being Tested
This study is a single arm, phase II pilot design. The study will evaluate ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-02
Trial ID
NCT05821686
Treatments Being Tested
The advent of checkpoint blockade immunotherapy has revolutionized the mana...
Status
Completed
Location
UC Davis Medical Center
Start Date
2017-08-11
Trial ID
NCT03224871
Treatments Being Tested
This is a phase I/II study that will evaluate the safety and toxicity of th...
Status
Active Not Recruiting
Location
UC Davis Medical Center
Start Date
2019-05-20
Trial ID
NCT03474497
Treatments Being Tested
This study is meant to assess the use of intralesional IL-2 to modulate the...
Status
Terminated
Location
Queen Elizabeth II Health Sciences Centre
Start Date
2019-10-30
Trial ID
NCT03233828
Treatments Being Tested
RATIONALE: Biological therapies, such as cellular adoptive immunotherapy, m...
Status
Completed
Location
Hoag Cancer Center at Hoag Memorial Hospital Presbyterian
Start Date
1999-02
Trial ID
NCT00331526
Treatments Being Tested